Barbara Handelin
CEO
- Audacity Therapeutics
Dr. Barbara Handelin is currently cofounder and CEO of Audacity Therapeutics, a public benefit (B Corp) pharmaceutical company. Previously, she was the cofounder of several companies and organizations, including: BioPontis Alliance for Rare Diseases, a nonprofit organization dedicated to developing new therapies for rare genetic diseases; Genovo, a gene therapy company; Kenna Technologies, a biosimulation company; and BioPontis Alliance, a novel Fund designed to bridge the gap between academic science and the product pipelines of the biotech industry. Dr. Handelin obtained her Ph.D. at the Oregon Health Sciences University with thesis work completed at MIT.